When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental When it comes to what they pay for their ...

A steady stream of customers walk into the From the Earth dispensary on Southwest Boulevard each day. They present IDs, make ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Court documents gave details of a website called LeafedOut that linked dealers with customers across Sydney, with either side allowed to leave reviews for each other and look at drug menus.

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug trial disappointed investors hoping for another blockbuster weight-loss drug. The Ozempic-maker's ...